Avenue Therapeutics (ATXI) Institutional Ownership $1.36 -0.04 (-2.86%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.32 -0.04 (-2.94%) As of 02/21/2025 07:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Institutional Ownership Changes (13F Filings) for Avenue Therapeutics (NASDAQ:ATXI)CurrentInstitutional OwnershipPercentage17.34%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$372.07KNumber ofInstitutional Sellers(last 12 months)0 Get ATXI Insider Trade Alerts Want to know when executives and insiders are buying or selling Avenue Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ATXI Institutional Buying and Selling by Quarter Avenue Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2025 Boothbay Fund Management LLC41,089$82K0.0%N/A2.004% 10/18/2024 Moss Adams Wealth Advisors LLC11,000$27K0.0%N/A1.169% 8/15/2024 Armistice Capital LLC75,000$262K0.0%N/A7.970% 1/28/2022National Asset Management Inc.71,338$65K0.0%-20.1%0.376% 11/16/2021National Asset Management Inc.89,237$133K0.0%-29.2%0.531% 10/19/2021 Kestra Advisory Services LLC22,500$34K0.0%N/A0.134% 9/17/2021 Virtu Financial LLC26,373$66K0.0%N/A0.157% 9/3/2021Parametric Portfolio Associates LLC10,554$26K0.0%-59.2%0.063% 8/16/2021 Occudo Quantitative Strategies LP14,398$36K0.0%N/A0.086% 8/13/2021 Renaissance Technologies LLC78,314$197K0.0%N/A0.468% Get the Latest News and Ratings for ATXI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avenue Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/13/2021 Northern Trust Corp13,767$35K0.0%-82.1%0.082% 8/13/2021 Geode Capital Management LLC79,556$199K0.0%-40.0%0.475% 8/13/2021 Vanguard Group Inc.449,982$1.13M0.0%-35.5%2.687% 8/12/2021 XTX Topco Ltd10,864$27K0.0%N/A0.065% 8/12/2021 Advisory Services Network LLC35,121$88K0.0%N/A0.210% 8/12/2021Ergoteles LLC30,400$76K0.0%N/A0.182% 8/10/2021National Asset Management Inc.126,037$317K0.0%-26.1%0.753% 5/20/2021Axiom Investment Management LLC10,000$60K0.0%N/A0.060% 5/19/2021 Squarepoint Ops LLC11,668$71K0.0%N/A0.070% 5/17/2021 Goldman Sachs Group Inc.17,319$105K0.0%N/A0.103% 5/13/2021 Trexquant Investment LP13,874$84K0.0%N/A0.083% 5/13/2021Axiom Investment Management LLC10,000$60K0.0%N/A0.060% 5/13/2021 Barclays PLC5,568$34K0.0%+159.0%0.033% 5/12/2021 Northern Trust Corp77,049$467K0.0%-6.8%0.460% 5/12/2021 Geode Capital Management LLC132,594$804K0.0%+5.9%0.792% 2/24/2021 Virtu Financial LLC17,469$104K0.0%N/A0.104% 2/19/2021 JPMorgan Chase & Co.17,102$101K0.0%+260.2%0.102% 2/17/2021 Jane Street Group LLC13,288$79K0.0%N/A0.079% 2/11/2021 Northern Trust Corp82,691$492K0.0%+2.1%0.494% 2/9/2021 Wells Fargo & Company MN16,406$98K0.0%-13.2%0.098% 2/5/2021BlackRock Inc.361,486$2.15M0.0%+5.5%2.158% (Data available from 1/1/2016 forward) ATXI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ATXI shares? During the previous two years, the following institutional investors and hedge funds held shares of Avenue Therapeutics shares: Armistice Capital LLC ($262K), and Boothbay Fund Management LLC ($82K), Moss Adams Wealth Advisors LLC ($27K).Learn more on ATXI's institutional investors. What percentage of Avenue Therapeutics stock is owned by institutional investors? 17.34% of Avenue Therapeutics stock is owned by institutional investors. Learn more on ATXI's institutional investor holdings. Which institutional investors have been buying Avenue Therapeutics stock? The following institutional investors have purchased Avenue Therapeutics stock in the last 24 months: Armistice Capital LLC ($75K), Boothbay Fund Management LLC ($41.09K), and Moss Adams Wealth Advisors LLC ($11K). How much institutional buying is happening at Avenue Therapeutics? Institutional investors have bought a total of 127,089 shares in the last 24 months. This purchase volume represents approximately $372.07K in transactions. Related Companies Turnstone Biologics Major Shareholders Brainstorm Cell Therapeutics Major Shareholders Jaguar Health Major Shareholders Bright Green Major Shareholders Chromocell Therapeutics Major Shareholders Relmada Therapeutics Major Shareholders NLS Pharmaceutics Major Shareholders Aytu BioPharma Major Shareholders Aptorum Group Major Shareholders AIM ImmunoTech Major Shareholders This page (NASDAQ:ATXI) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avenue Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avenue Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATXI Stock Alerts